Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Aug 17, 2021

ExxonMobil Continues to Optimize Its Asset Base
Image Source: ExxonMobil Corporation – Second Quarter of 2021 IR Earnings Presentation. According to Reuters, ExxonMobil Corp is in the process of divesting its Fayetteville shale play position in Arkansas, which ExxonMobil’s spokeswoman Julie King confirmed according to the news outlet. This is an upstream asset focused on the extraction of natural gas from the ground via “fracking” techniques (combing horizontal drilling and hydraulic fracturing to unlock raw energy resources from the ground).

Aug 12, 2021

Dividend Growth Idea Qualcomm Enters Bidding War to Bolster Automotive Growth Runway
Image Source: Qualcomm Inc – March 2021 Annual Meeting of Stockholders Presentation. One of our favorite semiconductor plays is Qualcomm. For those just getting familiar with the name, the company is about much more than just supplying components used in smartphones. While the rollout of 5G-capable smartphones will provide Qualcomm’s medium-term financial performance a large boost due to its Snapdragon mobile platform offerings, another key aspect of Qualcomm’s promising growth story is its exposure to the automotive industry.

Aug 6, 2021

ExxonMobil’s Great Earnings Report and Promising Growth Outlook
Image Shown: An overview of ExxonMobil Corporation’s strategy to generate shareholder value going forward. Image Source: ExxonMobil Corporation – Second Quarter of 2021 Earnings IR Presentation. ExxonMobil’s financial performance is on the upswing, and its operational performance has been firing on all cylinders of late. We continue to be big fans of both ExxonMobil’s capital appreciation upside and dividend growth potential. Our fair value estimate for ExxonMobil under our “base” case scenario sits at $83 per share, well above where shares of XOM are trading as of this writing. The company’s Dividend Cushion ratio sits near parity at 0.9, and we rate both ExxonMobil’s Dividend Growth and Dividend Safety ratings as “GOOD” given its impressive cash flow generating potential. Shares of XOM yield a nice ~6.0% as of this writing.

Aug 6, 2021

Dividend Increases/Decreases for the Week August 6
Let's take a look at companies that raised/lowered their dividend this week.

Aug 3, 2021

Chevron Posts a Great Earnings Update, Share Repurchases to Resume
Image Shown: An overview of Chevron Corporation’s performance in the second quarter of 2021. We include shares of Chevron as an idea in both our Best Ideas Newsletter and Dividend Growth Newsletter portfolios and continue to be huge fans of the name as the global energy complex continues to recover from the worst of the coronavirus (‘COVID-19 pandemic). Image Source: Chevron Corporation – Second Quarter of 2021 IR Earnings Presentation. The global energy complex continues to recover from the worst of the COVID-19 pandemic, and that speaks quite favorably to Chevron’s outlook. Management is committed to improving the company’s balance sheet strength going forward, which we really appreciate. Chevron’s free cash flow performance in the second quarter highlights the incredibly powerful positive effect the recovery is having on its financial performance. Share buybacks, in moderation, represent a good use of capital in our view (based on where shares of CVX are trading at as of this writing). With all of this in mind, we would like to stress that Chevron remains committed to its dividend (the firm moderately boosted its quarterly dividend during the second quarter of 2021 by ~4% sequentially). We continue to like Chevron as an idea in both the Best Ideas Newsletter portfolio and Dividend Growth Newsletter portfolio.

Jul 26, 2021

Chinese Stocks Getting Hammered
Image shown: A confluence of factors are driving Chinese stocks lower, not the least of which is heightened regulatory concerns.Investing is really simple. You don’t need to find terribly underfollowed ideas to do well, just mispriced ones. For example, Alphabet is up over 80% the past 52 weeks, and the company has been a top weighting in the Best Ideas Newsletter portfolio for some time. Facebook has also been an outperformer. There’s no need to make things complicated. Focus on undervalued stocks on a DCF basis that have strong market support through relative strength or a solid technical breakout--and stay away from those net-debt heavy, low valuation multiple value traps!

Jul 24, 2021

Best Ideas Newsletter Portfolio Soars!
Image shown: The top weighted ideas in the Best Ideas Newsletter portfolio continued to lead the charge during the trading session Friday, July 23. Facebook and Alphabet rallied on favorable reports from social media peers, while Vertex continues to recover thanks in part to encouraging views on CRISPR technology, while Visa looks to be back on track. DPZ had a strong trading session July 22 and experienced some profit taking. Image source: Seeking Alpha. The digital economy is here to stay, and online advertising is not a luxury but rather a necessity. Though many aren’t too big of fans of Facebook, the company, its stock continues to be severely underpriced, as its Shops and Dating features remain under-monetized, while potential at other properties such as Messenger and WhatsApp remain in the early innings, in our view. Our valuation of Facebook doesn’t include the tremendous promise that it holds in other areas of nascent growth and largely only considers Facebook/Instagram, meaning there is further upside potential beyond our fair value estimate range. Alphabet is benefiting from a lot of similar trends.

Jul 23, 2021

Dividend Increases/Decreases for the Week July 23
Let's take a look at companies that raised/lowered their dividend this week.

Jul 22, 2021

Johnson & Johnson Beats Estimates, Raises Guidance Once Again
Image Source: Johnson & Johnson – Second Quarter of 2021 IR Earnings Presentation. On July 21, Johnson & Johnson reported second-quarter 2021 earnings that beat both consensus top- and bottom-line estimates. The company (once again) boosted its full-year guidance in conjunction with its latest earnings update as Johnson & Johnson’s business is steadily rebounding from the worst of the coronavirus (‘COVID-19’) pandemic, with an eye towards the ongoing recovery in the sales of its medical devices and related offerings. We include shares of JNJ as an idea in both the Best Ideas Newsletter and Dividend Growth Newsletter portfolios. Its latest earnings report and guidance boost reinforced our favorable view towards the name. Shares of JNJ yield ~2.5% as of this writing, and the top end of our recently updated fair value estimate range sits at $206 per share of Johnson & Johnson, well above where shares are trading at as of this writing.

Jul 21, 2021

Philip Morris’ Transformation Continues
Image Shown: Philip Morris International Inc’s IQOS offering, a heated tobacco unit product (also classified as a “reduced risk product” by the company) that seeks to replicate the experience of traditional cigarettes for smokers in a bid to get those users to switch over to an offering the company views as relatively “safer,” has continued to post solid user base growth of late. We are big fans of Philip Morris and its ongoing transformation and include shares of PM as an idea in the High Yield Dividend Newsletter portfolio. Image Source: Philip Morris International Inc – Second Quarter of 2021 IR Earnings Presentation. On July 20, the company behind the Marlboro cigarette brand (excluding sales of the cigarette brand in the US) and the smokeless IQOS nicotine offering Philip Morris International reported second quarter 2021 earnings. The company missed consensus top-line estimates but beat consensus bottom-line estimates and boosted its full-year guidance for 2021 in conjunction with the report. Now Philip Morris expects to generate (the following are non-GAAP metrics) organic net revenue growth of 6%-7% (up from 5%-7% previously) and adjusted diluted EPS growth of 12%-14% (up from 11%-13% previously) on an annual basis in 2021 as its business steadily recovers from the worst of the coronavirus (‘COVID-19’) pandemic.